<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Petrlova J</submitter><funding>Alfred Österlunds Stiftelse</funding><funding>Crafoordska Stiftelsen</funding><funding>Vetenskapsrådet</funding><funding>LEO Foundation</funding><funding>Torsten Söderbergs Stiftelse</funding><funding>Petrus och Augusta Hedlunds Stiftelse</funding><funding>Greta och Johan Kocks stiftelser</funding><pagination>2566-2575</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9538650</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>596(19)</volume><pubmed_abstract>SARS-CoV-2 spike (S) protein is crucial for virus invasion in COVID-19. Here, we showed that lipopolysaccharide (LPS) can trigger S protein aggregation at high doses of LPS and S protein. We demonstrated the formation of S protein aggregates by microscopy analyses, aggregation and gel shift assays. LPS at high levels boosts the formation of S protein aggregates as detected by amytracker and thioflavin T dyes that specifically bind to aggregating proteins. We validated the role of LPS by blocking the formation of aggregates by the endotoxin-scavenging thrombin-derived peptide TCP-25. Aggregation-prone sequences in S protein are predicted to be nearby LPS binding sites, while molecular simulations showed stable formation of S protein-LPS higher-order oligomers. Collectively, our results provide evidence of LPS-induced S protein aggregation.</pubmed_abstract><journal>FEBS letters</journal><pubmed_title>SARS-CoV-2 spike protein aggregation is triggered by bacterial lipopolysaccharide.</pubmed_title><pmcid>PMC9538650</pmcid><funding_grant_id>LF-OC-20-000435</funding_grant_id><funding_grant_id>2017‐02341</funding_grant_id><funding_grant_id>2020‐02016</funding_grant_id><pubmed_authors>Bond PJ</pubmed_authors><pubmed_authors>Samsudin F</pubmed_authors><pubmed_authors>Petrlova J</pubmed_authors><pubmed_authors>Schmidtchen A</pubmed_authors></additional><is_claimable>false</is_claimable><name>SARS-CoV-2 spike protein aggregation is triggered by bacterial lipopolysaccharide.</name><description>SARS-CoV-2 spike (S) protein is crucial for virus invasion in COVID-19. Here, we showed that lipopolysaccharide (LPS) can trigger S protein aggregation at high doses of LPS and S protein. We demonstrated the formation of S protein aggregates by microscopy analyses, aggregation and gel shift assays. LPS at high levels boosts the formation of S protein aggregates as detected by amytracker and thioflavin T dyes that specifically bind to aggregating proteins. We validated the role of LPS by blocking the formation of aggregates by the endotoxin-scavenging thrombin-derived peptide TCP-25. Aggregation-prone sequences in S protein are predicted to be nearby LPS binding sites, while molecular simulations showed stable formation of S protein-LPS higher-order oligomers. Collectively, our results provide evidence of LPS-induced S protein aggregation.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-04T22:32:45.222Z</modification><creation>2025-02-19T03:23:05.587Z</creation></dates><accession>S-EPMC9538650</accession><cross_references><pubmed>36050806</pubmed><doi>10.1002/1873-3468.14490</doi></cross_references></HashMap>